Selected Cell
Cell:
Value:
Sheet1
A
B
C
D
E
F
G
H
I
J
1001
1002
1003
1004
1005
1006
1007
1008
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
"GO:BP" | "atrioventricular valve morphogenesis" | "GO:0003181" | "4.0407687338619497e-7" | "6.393536004910417" | "24" | "645" | "11" | "18092" | "TGFBR2 |
"GO:BP" | "response to tumor necrosis factor" | "GO:0034612" | "4.098368248333758e-7" | "6.387389021768368" | "329" | "645" | "38" | "18092" | "VCAM1 |
"GO:BP" | "biomineral tissue development" | "GO:0031214" | "4.137729770919685e-7" | "6.3832378758816475" | "165" | "645" | "26" | "18092" | "P2RX7 |
"GO:BP" | "cardiac muscle hypertrophy" | "GO:0003300" | "4.336164112936983e-7" | "6.362894289201643" | "108" | "645" | "21" | "18092" | "NOTCH1 |
"GO:BP" | "cardiac chamber morphogenesis" | "GO:0003206" | "4.361774209833772e-7" | "6.360336819720471" | "130" | "645" | "23" | "18092" | "TGFBR2 |
"GO:BP" | "nephron morphogenesis" | "GO:0072028" | "4.482919814363162e-7" | "6.3484390292562365" | "78" | "645" | "18" | "18092" | "BCL2 |
"GO:BP" | "renal tubule morphogenesis" | "GO:0061333" | "4.482919814363162e-7" | "6.3484390292562365" | "78" | "645" | "18" | "18092" | "BCL2 |
"GO:BP" | "regulation of neurogenesis" | "GO:0050767" | "4.6292858455655155e-7" | "6.334486001909128" | "376" | "645" | "41" | "18092" | "MYB |
"GO:BP" | "cranial skeletal system development" | "GO:1904888" | "4.741986411256725e-7" | "6.324039694880116" | "69" | "645" | "17" | "18092" | "TGFBR2 |
"GO:BP" | "hindbrain development" | "GO:0030902" | "4.74435654900507e-7" | "6.3238226802157325" | "166" | "645" | "26" | "18092" | "BCL2 |
"GO:BP" | "organic substance catabolic process" | "GO:1901575" | "4.931999154759496e-7" | "6.306977006505202" | "2271" | "645" | "137" | "18092" | "PLK2 |
"GO:BP" | "axonogenesis" | "GO:0007409" | "4.999245449632004e-7" | "6.3010955400219855" | "489" | "645" | "48" | "18092" | "APP |
"GO:BP" | "positive regulation of mitotic cell cycle" | "GO:0045931" | "5.305166672897242e-7" | "6.27530096727961" | "120" | "645" | "22" | "18092" | "CCND1 |
"GO:BP" | "biomineralization" | "GO:0110148" | "5.433879861797572e-7" | "6.264889967672849" | "167" | "645" | "26" | "18092" | "P2RX7 |
"GO:BP" | "anion transport" | "GO:0006820" | "5.518107730448705e-7" | "6.258209825008937" | "2914" | "645" | "165" | "18092" | "E2F3 |
"GO:BP" | "signal transduction involved in mitotic cell cycle checkpoint" | "GO:0072413" | "5.868052106746915e-7" | "6.231506038391778" | "61" | "645" | "16" | "18092" | "PLK2 |
"GO:BP" | "signal transduction involved in mitotic DNA damage checkpoint" | "GO:1902402" | "5.868052106746915e-7" | "6.231506038391778" | "61" | "645" | "16" | "18092" | "PLK2 |
"GO:BP" | "signal transduction involved in mitotic DNA integrity checkpoint" | "GO:1902403" | "5.868052106746915e-7" | "6.231506038391778" | "61" | "645" | "16" | "18092" | "PLK2 |
"GO:BP" | "negative regulation of cell-substrate adhesion" | "GO:0010812" | "6.058157208830061e-7" | "6.217659460940184" | "70" | "645" | "17" | "18092" | "PTEN |
"GO:BP" | "regulation of cell-substrate junction organization" | "GO:0150116" | "6.058157208830061e-7" | "6.217659460940184" | "70" | "645" | "17" | "18092" | "PTEN |
"GO:BP" | "regulation of protein modification by small protein conjugation or removal" | "GO:1903320" | "6.292976081040704e-7" | "6.201143918958342" | "247" | "645" | "32" | "18092" | "ITCH |
"GO:BP" | "endocardial cushion development" | "GO:0003197" | "6.356936527021118e-7" | "6.196752124907769" | "45" | "645" | "14" | "18092" | "TGFBR2 |
"GO:BP" | "tube formation" | "GO:0035148" | "6.415781146447034e-7" | "6.192750459018077" | "156" | "645" | "25" | "18092" | "VEGFA |
"GO:BP" | "mesenchyme morphogenesis" | "GO:0072132" | "6.569305968112913e-7" | "6.182480510218015" | "53" | "645" | "15" | "18092" | "TGFBR2 |
"GO:BP" | "regulation of cellular senescence" | "GO:2000772" | "6.569305968112913e-7" | "6.182480510218015" | "53" | "645" | "15" | "18092" | "CDK6 |
"GO:BP" | "leukocyte activation involved in immune response" | "GO:0002366" | "6.783815173873127e-7" | "6.168525993012615" | "719" | "645" | "61" | "18092" | "MYB |
"GO:BP" | "negative regulation of binding" | "GO:0051100" | "7.104818508766504e-7" | "6.148447011564512" | "169" | "645" | "26" | "18092" | "CDKN1A |
"GO:BP" | "striated muscle hypertrophy" | "GO:0014897" | "7.405828087439728e-7" | "6.130426373510293" | "111" | "645" | "21" | "18092" | "NOTCH1 |
"GO:BP" | "cellular component morphogenesis" | "GO:0032989" | "7.761665238994434e-7" | "6.110045092334558" | "813" | "645" | "66" | "18092" | "WEE1 |
"GO:BP" | "ion transport" | "GO:0006811" | "7.940118127813944e-7" | "6.100173036379436" | "3689" | "645" | "197" | "18092" | "E2F3 |
"GO:BP" | "B cell activation" | "GO:0042113" | "8.248514725138562e-7" | "6.0836242459650265" | "337" | "645" | "38" | "18092" | "CDKN1A |
"GO:BP" | "male gonad development" | "GO:0008584" | "8.525969936513699e-7" | "6.069256203055205" | "146" | "645" | "24" | "18092" | "CCND1 |
"GO:BP" | "positive regulation of secretion by cell" | "GO:1903532" | "8.708573714213149e-7" | "6.060052967698294" | "293" | "645" | "35" | "18092" | "MYB |
"GO:BP" | "regulation of circadian rhythm" | "GO:0042752" | "8.713603020692005e-7" | "6.0598022297858645" | "123" | "645" | "22" | "18092" | "NR1H3 |
"GO:BP" | "pancreas development" | "GO:0031016" | "8.715719020253736e-7" | "6.0596967791050265" | "81" | "645" | "18" | "18092" | "CDK6 |
"GO:BP" | "cellular protein localization" | "GO:0034613" | "8.796419696336684e-7" | "6.055694057681559" | "2024" | "645" | "125" | "18092" | "E2F3 |
"GO:BP" | "dsRNA processing" | "GO:0031050" | "8.799791478233672e-7" | "6.055527618864084" | "54" | "645" | "15" | "18092" | "ESR1 |
"GO:BP" | "production of small RNA involved in gene silencing by RNA" | "GO:0070918" | "8.799791478233672e-7" | "6.055527618864084" | "54" | "645" | "15" | "18092" | "ESR1 |
"GO:BP" | "ovulation cycle process" | "GO:0022602" | "8.84139708313957e-7" | "6.053479104041455" | "46" | "645" | "14" | "18092" | "ESR1 |
"GO:BP" | "positive regulation of peptidyl-tyrosine phosphorylation" | "GO:0050731" | "9.740739564108532e-7" | "6.011408068129809" | "197" | "645" | "28" | "18092" | "VEGFA |
"GO:BP" | "development of primary male sexual characteristics" | "GO:0046546" | "9.85384459113683e-7" | "6.006394291436383" | "147" | "645" | "24" | "18092" | "CCND1 |
"GO:BP" | "muscle hypertrophy" | "GO:0014896" | "0.0000010471392547843466" | "5.979995559426308" | "113" | "645" | "21" | "18092" | "NOTCH1 |
"GO:BP" | "positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway" | "GO:0090100" | "0.0000010471392547843466" | "5.979995559426308" | "113" | "645" | "21" | "18092" | "BMPR2 |
"GO:BP" | "histone phosphorylation" | "GO:0016572" | "0.0000010475557216146598" | "5.979822866742436" | "39" | "645" | "13" | "18092" | "HMGA2 |
"GO:BP" | "receptor signaling pathway via JAK-STAT" | "GO:0007259" | "0.0000010537844744798433" | "5.977248204223472" | "172" | "645" | "26" | "18092" | "SOCS1 |
"GO:BP" | "regulation of intrinsic apoptotic signaling pathway" | "GO:2001242" | "0.0000010537844744798433" | "5.977248204223472" | "172" | "645" | "26" | "18092" | "BCL2 |
"GO:BP" | "cellular response to molecule of bacterial origin" | "GO:0071219" | "0.0000011313715672914382" | "5.94639473979359" | "225" | "645" | "30" | "18092" | "NR1H3 |
"GO:BP" | "regulation of vesicle-mediated transport" | "GO:0060627" | "0.0000011523660742913858" | "5.938409535852337" | "552" | "645" | "51" | "18092" | "PTEN |
"GO:BP" | "glandular epithelial cell differentiation" | "GO:0002067" | "0.000001170577849875957" | "5.931599698031217" | "55" | "645" | "15" | "18092" | "CDK6 |
"GO:BP" | "negative regulation of epithelial cell differentiation" | "GO:0030857" | "0.000001170577849875957" | "5.931599698031217" | "55" | "645" | "15" | "18092" | "CCND1 |
"GO:BP" | "atrioventricular valve development" | "GO:0003171" | "0.000001171802017720712" | "5.93114575851811" | "26" | "645" | "11" | "18092" | "TGFBR2 |
"GO:BP" | "positive regulation of cellular amide metabolic process" | "GO:0034250" | "0.0000011992707520915036" | "5.921082757797774" | "173" | "645" | "26" | "18092" | "APP |
"GO:BP" | "negative regulation of protein binding" | "GO:0032091" | "0.0000012055907905184362" | "5.918800078246759" | "103" | "645" | "20" | "18092" | "CDKN1A |
"GO:BP" | "cellular macromolecule localization" | "GO:0070727" | "0.0000012401610834731983" | "5.906521901031339" | "2035" | "645" | "125" | "18092" | "E2F3 |
"GO:BP" | "positive regulation of peptide secretion" | "GO:0002793" | "0.000001276314756788997" | "5.894042209408337" | "161" | "645" | "25" | "18092" | "P2RX7 |
"GO:BP" | "myeloid cell homeostasis" | "GO:0002262" | "0.0000014594708174261978" | "5.835804584442653" | "162" | "645" | "25" | "18092" | "CDK6 |
"GO:BP" | "regulation of cell-substrate junction assembly" | "GO:0090109" | "0.0000016420543128268962" | "5.784612482191659" | "65" | "645" | "16" | "18092" | "PTEN |
"GO:BP" | "ureteric bud morphogenesis" | "GO:0060675" | "0.0000016420543128268962" | "5.784612482191659" | "65" | "645" | "16" | "18092" | "BCL2 |
"GO:BP" | "regulation of focal adhesion assembly" | "GO:0051893" | "0.0000016420543128268962" | "5.784612482191659" | "65" | "645" | "16" | "18092" | "PTEN |
"GO:BP" | "cellular response to hydrogen peroxide" | "GO:0070301" | "0.0000017247325438771458" | "5.763278241879959" | "105" | "645" | "20" | "18092" | "MYB |
"GO:BP" | "cell proliferation involved in kidney development" | "GO:0072111" | "0.0000017398520756136304" | "5.7594876744045616" | "21" | "645" | "10" | "18092" | "GPC3 |
"GO:BP" | "regulation of protein localization to membrane" | "GO:1905475" | "0.0000017508919494428362" | "5.756740654149933" | "202" | "645" | "28" | "18092" | "BCL2 |
"GO:BP" | "developmental cell growth" | "GO:0048588" | "0.0000017633680355419223" | "5.753657035900315" | "243" | "645" | "31" | "18092" | "APP |
"GO:BP" | "negative regulation of DNA-binding transcription factor activity" | "GO:0043433" | "0.0000017822155174593963" | "5.749039779320531" | "189" | "645" | "27" | "18092" | "ITCH |
"GO:BP" | "response to laminar fluid shear stress" | "GO:0034616" | "0.0000018299834313672544" | "5.7375528423451705" | "16" | "645" | "9" | "18092" | "TGFB1 |
"GO:BP" | "embryonic appendage morphogenesis" | "GO:0035113" | "0.000001924418678845313" | "5.715700436388015" | "128" | "645" | "22" | "18092" | "RECK |
"GO:BP" | "formation of primary germ layer" | "GO:0001704" | "0.000001924418678845313" | "5.715700436388015" | "128" | "645" | "22" | "18092" | "HMGA2 |
"GO:BP" | "embryonic limb morphogenesis" | "GO:0030326" | "0.000001924418678845313" | "5.715700436388015" | "128" | "645" | "22" | "18092" | "RECK |
"GO:BP" | "regulation of nervous system development" | "GO:0051960" | "0.00000194335506996438" | "5.711447842303981" | "459" | "645" | "45" | "18092" | "MYB |
"GO:BP" | "limb morphogenesis" | "GO:0035108" | "0.0000019929818035877896" | "5.700496666496447" | "152" | "645" | "24" | "18092" | "RECK |
"GO:BP" | "appendage morphogenesis" | "GO:0035107" | "0.0000019929818035877896" | "5.700496666496447" | "152" | "645" | "24" | "18092" | "RECK |
"GO:BP" | "regulation of ossification" | "GO:0030278" | "0.000002044465054068914" | "5.689420308418397" | "117" | "645" | "21" | "18092" | "BCL2 |
"GO:BP" | "negative regulation of kinase activity" | "GO:0033673" | "0.0000020478231440149326" | "5.688707553016019" | "273" | "645" | "33" | "18092" | "SPRED1 |
"GO:BP" | "glomerulus development" | "GO:0032835" | "0.0000020967898984782437" | "5.678445084319051" | "66" | "645" | "16" | "18092" | "BCL2 |
"GO:BP" | "mesonephric tubule morphogenesis" | "GO:0072171" | "0.0000020967898984782437" | "5.678445084319051" | "66" | "645" | "16" | "18092" | "BCL2 |
"GO:BP" | "ear development" | "GO:0043583" | "0.0000021523934656024897" | "5.667078335087302" | "231" | "645" | "30" | "18092" | "BCL2 |
"GO:BP" | "peptidyl-lysine modification" | "GO:0018205" | "0.0000022270381990421655" | "5.652272333710933" | "412" | "645" | "42" | "18092" | "MYB |
"GO:BP" | "protein modification by small protein conjugation or removal" | "GO:0070647" | "0.0000022428536712625378" | "5.649199059825968" | "1185" | "645" | "84" | "18092" | "ITCH |
"GO:BP" | "regulation of DNA binding" | "GO:0051101" | "0.0000022437651591286786" | "5.649022599925541" | "129" | "645" | "22" | "18092" | "HMGA2 |
"GO:BP" | "positive regulation of vascular associated smooth muscle cell proliferation" | "GO:1904707" | "0.0000022542449062329887" | "5.646998902998124" | "49" | "645" | "14" | "18092" | "DNMT1 |
"GO:BP" | "positive regulation of phosphatidylinositol 3-kinase activity" | "GO:0043552" | "0.0000023120564585180027" | "5.636001565007803" | "34" | "645" | "12" | "18092" | "IRS1 |
"GO:BP" | "regulation of neuron projection development" | "GO:0010975" | "0.000002391775451469952" | "5.621279595906516" | "462" | "645" | "45" | "18092" | "CRK |
"GO:BP" | "nephron epithelium morphogenesis" | "GO:0072088" | "0.00000240786951047256" | "5.618367052471218" | "76" | "645" | "17" | "18092" | "BCL2 |
"GO:BP" | "negative regulation of wound healing" | "GO:0061045" | "0.00000240786951047256" | "5.618367052471218" | "76" | "645" | "17" | "18092" | "CRK |
"GO:BP" | "regulation of muscle adaptation" | "GO:0043502" | "0.000002445648086580737" | "5.611606035055865" | "107" | "645" | "20" | "18092" | "NOTCH1 |
"GO:BP" | "positive regulation of protein binding" | "GO:0032092" | "0.0000024652457080488576" | "5.608139788625375" | "86" | "645" | "18" | "18092" | "PLK2 |
"GO:BP" | "positive regulation of peptidase activity" | "GO:0010952" | "0.000002465479326879744" | "5.6080986346902115" | "205" | "645" | "28" | "18092" | "APP |
"GO:BP" | "muscle adaptation" | "GO:0043500" | "0.0000026119774761582886" | "5.5830305724284885" | "130" | "645" | "22" | "18092" | "NOTCH1 |
"GO:BP" | "DNA damage checkpoint" | "GO:0000077" | "0.0000026187044732363413" | "5.581913509930815" | "154" | "645" | "24" | "18092" | "CCND1 |
"GO:BP" | "endothelium development" | "GO:0003158" | "0.0000026764506125653213" | "5.57244076606282" | "142" | "645" | "23" | "18092" | "VEGFA |
"GO:BP" | "regulation of generation of precursor metabolites and energy" | "GO:0043467" | "0.000002806896283940121" | "5.551773634442392" | "167" | "645" | "25" | "18092" | "APP |
"GO:BP" | "negative regulation of epithelial cell proliferation" | "GO:0050680" | "0.0000028842137979668752" | "5.539972549834793" | "180" | "645" | "26" | "18092" | "CDK6 |
"GO:BP" | "protein localization to organelle" | "GO:0033365" | "0.0000031022079690165257" | "5.50832909086518" | "1014" | "645" | "75" | "18092" | "E2F3 |
"GO:BP" | "anoikis" | "GO:0043276" | "0.0000034050338150535553" | "5.467878570794296" | "35" | "645" | "12" | "18092" | "BCL2 |
"GO:BP" | "regulation of histone modification" | "GO:0031056" | "0.0000034245469813525047" | "5.4653968713281715" | "156" | "645" | "24" | "18092" | "MYB |
"GO:BP" | "branching involved in ureteric bud morphogenesis" | "GO:0001658" | "0.000003437991654425003" | "5.4636951818786255" | "59" | "645" | "15" | "18092" | "BCL2 |
"GO:BP" | "substrate adhesion-dependent cell spreading" | "GO:0034446" | "0.0000034385449418158923" | "5.463625295051754" | "109" | "645" | "20" | "18092" | "CRK |
"GO:BP" | "B cell differentiation" | "GO:0030183" | "0.0000035498952932583407" | "5.449784456587372" | "144" | "645" | "23" | "18092" | "BCL2 |
"GO:BP" | "regulation of peptide hormone secretion" | "GO:0090276" | "0.0000035787599861967216" | "5.446267427110316" | "222" | "645" | "29" | "18092" | "IRS1 |
"GO:BP" | "male sex differentiation" | "GO:0046661" | "0.000003619212842169743" | "5.441385875730777" | "169" | "645" | "25" | "18092" | "CCND1 |
"GO:BP" | "receptor signaling pathway via STAT" | "GO:0097696" | "0.0000036745027844986213" | "5.43480141918053" | "182" | "645" | "26" | "18092" | "SOCS1 |
"GO:BP" | "regulation of DNA metabolic process" | "GO:0051052" | "0.0000037358933322568065" | "5.427605532301046" | "371" | "645" | "39" | "18092" | "CDKN1A |
"GO:BP" | "negative regulation of cytokine production" | "GO:0001818" | "0.0000037358933322568065" | "5.427605532301046" | "371" | "645" | "39" | "18092" | "ITCH |
"GO:BP" | "innate immune response" | "GO:0045087" | "0.0000037892471811322545" | "5.421447063793265" | "999" | "645" | "74" | "18092" | "ITCH |
"GO:BP" | "regulation of anion transmembrane transport" | "GO:1903959" | "0.000003875131792388943" | "5.411713522645681" | "121" | "645" | "21" | "18092" | "IRS1 |
"GO:BP" | "negative regulation of cellular component organization" | "GO:0051129" | "0.0000041340184421642815" | "5.383627590284368" | "753" | "645" | "61" | "18092" | "PTEN |
"GO:BP" | "positive regulation of gliogenesis" | "GO:0014015" | "0.0000042454778596731435" | "5.372073419639317" | "69" | "645" | "16" | "18092" | "MYB |
"GO:BP" | "vascular process in circulatory system" | "GO:0003018" | "0.00000433641585911765" | "5.362869075948496" | "252" | "645" | "31" | "18092" | "VEGFA |
"GO:BP" | "cellular response to decreased oxygen levels" | "GO:0036294" | "0.000004418769641079662" | "5.3546986384503" | "224" | "645" | "29" | "18092" | "BCL2 |
"GO:BP" | "leukocyte homeostasis" | "GO:0001776" | "0.000004432736760730181" | "5.353328058630013" | "89" | "645" | "18" | "18092" | "BCL2 |
"GO:BP" | "negative regulation of cellular catabolic process" | "GO:0031330" | "0.000004576674525446657" | "5.339449971738875" | "267" | "645" | "32" | "18092" | "BCL2 |
"GO:BP" | "regulation of cell morphogenesis" | "GO:0022604" | "0.000004744405296509414" | "5.323818217932351" | "312" | "645" | "35" | "18092" | "CRK |
"GO:BP" | "bone morphogenesis" | "GO:0060349" | "0.000004790744787292689" | "5.319596964274961" | "100" | "645" | "19" | "18092" | "TGFBR2 |
"GO:BP" | "positive regulation of peptidyl-serine phosphorylation" | "GO:0033138" | "0.000004795264532207741" | "5.3191874298469735" | "111" | "645" | "20" | "18092" | "APP |
"GO:BP" | "regulation of Notch signaling pathway" | "GO:0008593" | "0.000004795264532207741" | "5.3191874298469735" | "111" | "645" | "20" | "18092" | "KAT2B |
"GO:BP" | "endothelial cell differentiation" | "GO:0045446" | "0.00000527965765973551" | "5.2773942368048035" | "123" | "645" | "21" | "18092" | "VEGFA |
"GO:BP" | "negative regulation of cellular senescence" | "GO:2000773" | "0.000005289714423656701" | "5.2765677736317045" | "23" | "645" | "10" | "18092" | "CDK6 |
"GO:BP" | "response to hyperoxia" | "GO:0055093" | "0.000005289714423656701" | "5.2765677736317045" | "23" | "645" | "10" | "18092" | "CDKN1A |
"GO:BP" | "cardiac cell development" | "GO:0055006" | "0.00000535951750828144" | "5.270874306001773" | "90" | "645" | "18" | "18092" | "VEGFA |
"GO:BP" | "cellular response to mechanical stimulus" | "GO:0071260" | "0.000005597474946026297" | "5.252007841621532" | "80" | "645" | "17" | "18092" | "TGFB1 |
"GO:BP" | "intrinsic apoptotic signaling pathway by p53 class mediator" | "GO:0072332" | "0.000005597474946026297" | "5.252007841621532" | "80" | "645" | "17" | "18092" | "CDKN1A |
"GO:BP" | "cardiac septum development" | "GO:0003279" | "0.00000564607874905547" | "5.248253068795947" | "112" | "645" | "20" | "18092" | "TGFBR2 |
"GO:BP" | "osteoclast differentiation" | "GO:0030316" | "0.000005707331647240743" | "5.243566890306882" | "101" | "645" | "19" | "18092" | "TGFB1 |
"GO:BP" | "negative regulation of neuron apoptotic process" | "GO:0043524" | "0.000005776484501941363" | "5.238336387513378" | "160" | "645" | "24" | "18092" | "BCL2 |
"GO:BP" | "anatomical structure maturation" | "GO:0071695" | "0.000005975411225566345" | "5.223632201367475" | "241" | "645" | "30" | "18092" | "APP |
"GO:BP" | "regulation of fat cell differentiation" | "GO:0045598" | "0.000006148555818425367" | "5.211226879954956" | "148" | "645" | "23" | "18092" | "E2F1 |
"GO:BP" | "positive regulation of nervous system development" | "GO:0051962" | "0.000006183404853329923" | "5.208772317497401" | "285" | "645" | "33" | "18092" | "MYB |
"GO:BP" | "embryonic placenta development" | "GO:0001892" | "0.000006462327541552743" | "5.189611033646764" | "91" | "645" | "18" | "18092" | "EOMES |
"GO:BP" | "negative regulation of response to wounding" | "GO:1903035" | "0.000006462327541552743" | "5.189611033646764" | "91" | "645" | "18" | "18092" | "CRK |
"GO:BP" | "cellular response to hypoxia" | "GO:0071456" | "0.000006609920744250573" | "5.179803747857929" | "214" | "645" | "28" | "18092" | "BCL2 |
"GO:BP" | "blood coagulation" | "GO:0007596" | "0.000006684206032758858" | "5.1749501719577" | "347" | "645" | "37" | "18092" | "P2RX7 |
"GO:BP" | "cell death in response to oxidative stress" | "GO:0036473" | "0.000006783887068942726" | "5.168521390371513" | "102" | "645" | "19" | "18092" | "BCL2 |
"GO:BP" | "regulation of oxidative stress-induced cell death" | "GO:1903201" | "0.0000068527929420890374" | "5.164132390241074" | "81" | "645" | "17" | "18092" | "SIRT1 |
"GO:BP" | "glucose import" | "GO:0046323" | "0.0000068527929420890374" | "5.164132390241074" | "81" | "645" | "17" | "18092" | "IRS1 |
"GO:BP" | "regulation of glial cell proliferation" | "GO:0060251" | "0.000007080228644357841" | "5.14995271725662" | "37" | "645" | "12" | "18092" | "MYB |
"GO:BP" | "negative regulation of gene silencing by miRNA" | "GO:0060965" | "0.000007293869741803912" | "5.137041996838102" | "18" | "645" | "9" | "18092" | "ESR1 |
"GO:BP" | "regulation of canonical Wnt signaling pathway" | "GO:0060828" | "0.000007365240242502907" | "5.132813082590301" | "302" | "645" | "34" | "18092" | "RECK |
"GO:BP" | "regulation of cellular response to oxidative stress" | "GO:1900407" | "0.000007771248936417424" | "5.109509179061854" | "92" | "645" | "18" | "18092" | "SIRT1 |
"GO:BP" | "regulation of carbohydrate metabolic process" | "GO:0006109" | "0.00000816488052759365" | "5.0880501656837644" | "216" | "645" | "28" | "18092" | "APP |
"GO:BP" | "positive regulation of osteoblast differentiation" | "GO:0045669" | "0.000008269346191848509" | "5.082528826178657" | "72" | "645" | "16" | "18092" | "BMPR2 |
"GO:BP" | "positive regulation of protein secretion" | "GO:0050714" | "0.000008347242366129424" | "5.078456976370031" | "138" | "645" | "22" | "18092" | "P2RX7 |
"GO:BP" | "learning or memory" | "GO:0007611" | "0.000008720033265356218" | "5.059481858309051" | "274" | "645" | "32" | "18092" | "PLK2 |
"GO:BP" | "regulation of production of small RNA involved in gene silencing by RNA" | "GO:0070920" | "0.000008779455530992757" | "5.0565324165788" | "24" | "645" | "10" | "18092" | "ESR1 |
"GO:BP" | "regulation of production of miRNAs involved in gene silencing by miRNA" | "GO:1903798" | "0.000008779455530992757" | "5.0565324165788" | "24" | "645" | "10" | "18092" | "ESR1 |
"GO:BP" | "developmental growth involved in morphogenesis" | "GO:0060560" | "0.000008840437824945917" | "5.053526225908931" | "245" | "645" | "30" | "18092" | "APP |
"GO:BP" | "endoderm formation" | "GO:0001706" | "0.00000918714141030276" | "5.036819598826498" | "54" | "645" | "14" | "18092" | "HMGA2 |
"GO:BP" | "regulation of gliogenesis" | "GO:0014013" | "0.000009521391646816876" | "5.0212995704849845" | "104" | "645" | "19" | "18092" | "MYB |
"GO:BP" | "sensory organ morphogenesis" | "GO:0090596" | "0.00000954256773759328" | "5.020334748543279" | "275" | "645" | "32" | "18092" | "BCL2 |
"GO:BP" | "DNA integrity checkpoint" | "GO:0031570" | "0.000009574488066113812" | "5.0188844378298985" | "164" | "645" | "24" | "18092" | "CCND1 |
"GO:BP" | "hemostasis" | "GO:0007599" | "0.000009880568522005777" | "5.005218065648566" | "352" | "645" | "37" | "18092" | "P2RX7 |
"GO:BP" | "positive regulation of lipid kinase activity" | "GO:0090218" | "0.000010014923880388923" | "4.999352347264333" | "38" | "645" | "12" | "18092" | "IRS1 |
"GO:BP" | "negative regulation of cell activation" | "GO:0050866" | "0.000010058012458012052" | "4.997487830790798" | "218" | "645" | "28" | "18092" | "ITCH |
"GO:BP" | "biological process involved in interaction with host" | "GO:0051701" | "0.000010058012458012052" | "4.997487830790798" | "218" | "645" | "28" | "18092" | "ITCH |
"GO:BP" | "negative regulation of growth" | "GO:0045926" | "0.000010195506399869906" | "4.991591198408913" | "261" | "645" | "31" | "18092" | "CDKN1A |
"GO:BP" | "mammary gland epithelium development" | "GO:0061180" | "0.000010245235116665296" | "4.989478070576727" | "73" | "645" | "16" | "18092" | "CCND1 |
"GO:BP" | "cellular chemical homeostasis" | "GO:0055082" | "0.000010275504871470291" | "4.988196830521776" | "847" | "645" | "65" | "18092" | "APP |
"GO:BP" | "regulation of T cell differentiation" | "GO:0045580" | "0.000010441408940683744" | "4.981240894640411" | "152" | "645" | "23" | "18092" | "MYB |
"GO:BP" | "inner ear development" | "GO:0048839" | "0.000010965701486696812" | "4.959963580853134" | "205" | "645" | "27" | "18092" | "SOX2 |
"GO:BP" | "sprouting angiogenesis" | "GO:0002040" | "0.000010965701486696812" | "4.959963580853134" | "205" | "645" | "27" | "18092" | "SPRED1 |
"GO:BP" | "artery development" | "GO:0060840" | "0.00001124390935560586" | "4.949082664177979" | "105" | "645" | "19" | "18092" | "VEGFA |
"GO:BP" | "coagulation" | "GO:0050817" | "0.000012441667862619402" | "4.90512139657613" | "355" | "645" | "37" | "18092" | "P2RX7 |
"GO:BP" | "epithelial tube formation" | "GO:0072175" | "0.000012610256778283977" | "4.899276069949011" | "141" | "645" | "22" | "18092" | "VEGFA |
"GO:BP" | "nephron tubule morphogenesis" | "GO:0072078" | "0.00001264531827925356" | "4.898070235106927" | "74" | "645" | "16" | "18092" | "BCL2 |
"GO:BP" | "positive regulation of lymphocyte differentiation" | "GO:0045621" | "0.000013250458238573157" | "4.877769102327739" | "106" | "645" | "19" | "18092" | "MYB |
"GO:BP" | "positive regulation of histone modification" | "GO:0031058" | "0.000013307699715819477" | "4.875897007415023" | "95" | "645" | "18" | "18092" | "MYB |
"GO:BP" | "negative regulation of gene silencing by RNA" | "GO:0060967" | "0.000013420812397584978" | "4.872221194367512" | "19" | "645" | "9" | "18092" | "ESR1 |
"GO:BP" | "kidney mesenchyme development" | "GO:0072074" | "0.000013420812397584978" | "4.872221194367512" | "19" | "645" | "9" | "18092" | "PKD2 |
"GO:BP" | "negative regulation of posttranscriptional gene silencing" | "GO:0060149" | "0.000013420812397584978" | "4.872221194367512" | "19" | "645" | "9" | "18092" | "ESR1 |
"GO:BP" | "T cell proliferation" | "GO:0042098" | "0.000013571269726114352" | "4.867379517907832" | "207" | "645" | "27" | "18092" | "ITCH |
"GO:BP" | "skeletal muscle organ development" | "GO:0060538" | "0.000013653081685681976" | "4.864769311404736" | "180" | "645" | "25" | "18092" | "BCL2 |
"GO:BP" | "steroid hormone mediated signaling pathway" | "GO:0043401" | "0.000014431454575332435" | "4.840689893286031" | "142" | "645" | "22" | "18092" | "ESR1 |
"GO:BP" | "regulation of organ growth" | "GO:0046620" | "0.000014467429970185155" | "4.839608611168374" | "118" | "645" | "20" | "18092" | "PTEN |
"GO:BP" | "response to cadmium ion" | "GO:0046686" | "0.00001465398828510727" | "4.834044159986538" | "65" | "645" | "15" | "18092" | "CHUK |
"GO:BP" | "focal adhesion assembly" | "GO:0048041" | "0.00001491798248766715" | "4.8262899070053775" | "85" | "645" | "17" | "18092" | "BCL2 |
"GO:BP" | "cell cycle checkpoint" | "GO:0000075" | "0.00001514104134946" | "4.819844254507567" | "222" | "645" | "28" | "18092" | "WEE1 |
"GO:BP" | "cardiac septum morphogenesis" | "GO:0060411" | "0.00001555050481818927" | "4.8082555078464475" | "75" | "645" | "16" | "18092" | "TGFBR2 |
"GO:BP" | "positive regulation of reactive oxygen species metabolic process" | "GO:2000379" | "0.000015583314975935047" | "4.807340151116782" | "107" | "645" | "19" | "18092" | "CDKN1A |
"GO:BP" | "negative regulation of cyclin-dependent protein serine/threonine kinase activity" | "GO:0045736" | "0.000016096069336989742" | "4.793280165811097" | "32" | "645" | "11" | "18092" | "CDKN1A |
"GO:BP" | "insulin secretion" | "GO:0030073" | "0.00001674394354339351" | "4.776142249004893" | "223" | "645" | "28" | "18092" | "IRS1 |
"GO:BP" | "system process" | "GO:0003008" | "0.00001678996026582279" | "4.774950331637671" | "2327" | "645" | "134" | "18092" | "PLK2 |
"GO:BP" | "intracellular steroid hormone receptor signaling pathway" | "GO:0030518" | "0.00001681948431500545" | "4.774187323792613" | "119" | "645" | "20" | "18092" | "ESR1 |
"GO:BP" | "mitotic cell cycle checkpoint" | "GO:0007093" | "0.000017592718406705127" | "4.75466704867129" | "169" | "645" | "24" | "18092" | "WEE1 |
"GO:BP" | "skeletal muscle tissue development" | "GO:0007519" | "0.000017592718406705127" | "4.75466704867129" | "169" | "645" | "24" | "18092" | "BCL2 |
"GO:BP" | "cellular response to metal ion" | "GO:0071248" | "0.000018160347151064618" | "4.740875853813241" | "196" | "645" | "26" | "18092" | "APP |
"GO:BP" | "positive regulation of nucleotide metabolic process" | "GO:0045981" | "0.00001851065599850959" | "4.732578190026968" | "48" | "645" | "13" | "18092" | "APP |
"GO:BP" | "positive regulation of purine nucleotide metabolic process" | "GO:1900544" | "0.00001851065599850959" | "4.732578190026968" | "48" | "645" | "13" | "18092" | "APP |
"GO:BP" | "regulation of I-kappaB kinase/NF-kappaB signaling" | "GO:0043122" | "0.000018836542807314264" | "4.724998803108021" | "253" | "645" | "30" | "18092" | "PLK2 |
"GO:BP" | "somatic stem cell population maintenance" | "GO:0035019" | "0.000019055207566913547" | "4.719986316129589" | "76" | "645" | "16" | "18092" | "SOX2 |
"GO:BP" | "regulation of cardiac muscle hypertrophy" | "GO:0010611" | "0.000019055207566913547" | "4.719986316129589" | "76" | "645" | "16" | "18092" | "NOTCH1 |
"GO:BP" | "regulation of lymphocyte differentiation" | "GO:0045619" | "0.000019235322187475146" | "4.715900534957855" | "183" | "645" | "25" | "18092" | "MYB |
"GO:BP" | "regulation of transforming growth factor beta production" | "GO:0071634" | "0.000019357003687797204" | "4.713161867201419" | "40" | "645" | "12" | "18092" | "MYB |
"GO:BP" | "positive regulation of protein localization to membrane" | "GO:1905477" | "0.00001962494492983587" | "4.70719155326816" | "132" | "645" | "21" | "18092" | "BCL2 |
"GO:BP" | "response to gamma radiation" | "GO:0010332" | "0.000019731185649182755" | "4.70484681715904" | "57" | "645" | "14" | "18092" | "CDKN1A |
"GO:BP" | "myeloid leukocyte activation" | "GO:0002274" | "0.00002008439956125074" | "4.697141147309626" | "673" | "645" | "55" | "18092" | "APP |
"GO:BP" | "protein-containing complex subunit organization" | "GO:0043933" | "0.00002088851923594092" | "4.6800923455847085" | "1974" | "645" | "118" | "18092" | "VEGFA |
"GO:BP" | "positive regulation of cell division" | "GO:0051781" | "0.000021623921604391417" | "4.665065541802576" | "87" | "645" | "17" | "18092" | "VEGFA |
"GO:BP" | "regulation of cellular amide metabolic process" | "GO:0034248" | "0.00002214316414752523" | "4.6547603205113015" | "531" | "645" | "47" | "18092" | "APP |
"GO:BP" | "regulation of protein acetylation" | "GO:1901983" | "0.000023269272540668717" | "4.633217193701313" | "77" | "645" | "16" | "18092" | "TGFB1 |
"GO:BP" | "regulation of kidney development" | "GO:0090183" | "0.00002337118882998486" | "4.631319195644972" | "33" | "645" | "11" | "18092" | "VEGFA |
"GO:BP" | "negative regulation of cyclin-dependent protein kinase activity" | "GO:1904030" | "0.00002337118882998486" | "4.631319195644972" | "33" | "645" | "11" | "18092" | "CDKN1A |